While researching and developing Tibetan medicines and enterprises, the company invested 10 million yuan to establish a sustainable medicinal planting base. The nursery base covers an area of about 500 mu, with honeysuckle as the leader, and has planted 32 kinds of Chinese herbal medicines suitable for planting in Shandong, and signed a cooperation agreement with three towns in Leling City to plant 6,000 mu of honeysuckle. At present, the company has shown a good trend of diversified development integrating raw material medicine planting base, processing, production and sales!
From June 5438, 2009 to October, 2009, the company has successfully entered the international capital market and opened a wide range of financing channels. At present, Hang Seng Ye Wei Group has signed an investment agreement of US$ 30 million with the group company, which has laid a good foundation for the company's development, such as bioengineering technology, production of Tibetan medicine soft capsules, cultivation of Chinese herbal medicines and development of Tibetan medicine health centers.